During the past decade, Polyclinique de l'Ormeau conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Polyclinique de l'Ormeau" #1 sponsor was "UNICANCER" with 5 trials, followed by "Federation Francophone de Cancerologie Digestive" with 2 trials sponsored, "Hospira, now a wholly owned subsidiary of Pfizer" with 2 trials sponsored, "Institut Claudius Regaud" with 2 trials sponsored and "Abbott Medical Devices" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Polyclinique de l'Ormeau" #1 collaborator was "Amgen" with 1 trials as a collaborator, "Association Francophone des Soins Oncologiques de Support" with 1 trials as a collaborator, "European Clinical Trial Experts Network" with 1 trials as a collaborator, "Federation of Medical Specialties" with 1 trials as a collaborator and "French National Platform Quality of Life and Cancer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Polyclinique de l'Ormeau" are "Breast Cancer" (3 trials), "Coronary Artery Disease" (2 trials), "Metastatic Colorectal Cancer" (2 trials), "Adenocarcinoma of Rectum" (1 trials) and "Aneurysm" (1 trials). Many other conditions were trialed in "Polyclinique de l'Ormeau" in a lesser frequency.

Most popular intervention types in "Polyclinique de l'Ormeau" are "Drug" (9 trials), "Other" (4 trials), "Device" (3 trials), "Procedure" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (3 trials), "epirubicin hydrochloride" (3 trials), "fluorouracil" (3 trials), "adjuvant therapy" (2 trials) and "A six-minute walking distance test" (1 trials). Other intervention names were less common.

The vast majority of trials in "Polyclinique de l'Ormeau" are 13 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Polyclinique de l'Ormeau". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Polyclinique de l'Ormeau, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Polyclinique de l'Ormeau, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".